The 9th Annual International Symposium of Drug Delivery Systems
Highlights

● Organize up to 200+ Oral Presentations on the Latest Tech Trend of Drug Delivery Systems
● 300+ Attendees Coming from All over the World to Exchange Ideas, Build New Networks, and Foster Friendships
● Bring together 50+ Project Posters on New Technologies Implemented in Industrial Manufacturing
● Learn Global Market Trends for Advanced Drug Delivery Systems
● Cutting-edge Keynote Addresses by Prominent Leaders from All over the World
● Opportunities to Visit the Netherlands's Natural and Cultural Landscapes

Keynote Speakers

Dr. Luc Van Hijfte
SVP Medicinal Chemistry, Mercachem bv, the Netherlands

Dr. Matthias von Herrath
Professor, La Jolla Institute; Vice President, NovoNordisk, USA

Dr. Dan Some
Principal Scientist, Wyatt Technology Corporation, USA

Dr. Balazs Sarkadi
Professor, Semmelweis University, Hungary

Dr. Uwe Schoenbeck,
Senior Vice President & Chief Scientific Officer, Worldwide R & D, Pfizer, USA
Dr. Zsolt Bosnyak,
VP, Global Medical Head Diabetes, Sanofi, France
Confirmed Renowned Speakers

Dr. Benno Rattel,
Executive Director, Nonclinical Development, Amgen Research, Germany

Dr. Alexey RAK,
Director of Bio Structure and Biophysics, Sanofi R&D, France

Dr. Loui Madakamutil,
SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA

Dr. Marcus Bauser,
Director, Medicinal Chemistry, Bayer AG, Germany

Dr. Finn Bauer,
Global Head of Solid Formulations R&D, Merck KGaA, Germany

Dr. Florian Montel,
Head of opnMe.com & CNS Project Leader, Boehringer Ingelheim, Germany

Dr. Henk Leeuwis,
Vice President, LioniX International, the Netherlands

Dr. Miriam Kidron,
CSO, Oramed Pharmaceuticals, Isreal

Dr. Ralf Glatthar,
Director, Novartis Pharma AG, Switzerland

Dr. Steve Faraci,
CSO, Cyta Therapeutics, USA

Dr. Frank Bartels,
CEO, Bartels Mikrotechnik GmbH, Germany

Dr. Sandrine Gerber-Lemaire,
Professor, EPFL Lausanne, Switzerland

Dr. Sam Dylan More,
CEO, DendroPharm, Germany

Dr. Michael Gamlen,
Chief Scientific Officer, Gamlen Tableting Ltd, UK

Dr. Karen S. Aboody,
Professor, City of Hope National Medical Center & Beckman Research Institute, USA

Dr. Immanuel Lerner,
Chief Executive Officer, Pepticom LTD, Isreal

Dr. Anthony W. Coleman,
Research Director, Université de Lyon, France

Dr. Mircea Ciuca,
Head, Medical Clinical Drug Safety, Vifor Pharma, Switzerland

Dr. Lucas P.J.J. Noldus,
Founder & CEO, Noldus Information Technology bv, the Netherlands

Dr. Wilbur de Kruijf,
VP, Medspray Pharma, the Netherlands

Dr. Hubert Pellikaan,
Nextstep Pharma BV, the Netherlands

Dr. Faz Chowdhury,
CEO, Nemaura Pharma Limited, UK

Dr. Joël Richard,
Head of Technical and Pharmaceutical Operations, MedinCell, France

Dr. Khursheed Anwer,
Executive Vice President & Chief Science Officer, Celsion Corporation, USA

Dr. Michael Gamlen,
Chief Scientific Officer, Gamlen Tableting Ltd., UK

Dr. Michael Black,
Head of Sales PHARMA, BENEO-Palatinit GmbH, Germany

Dr. Masha Poyurovsky,
Vice President, Kadmon Corporation, LLC, USA

Dr. Yaakov Naparstek,
Professor of Medicine, Hadassah University Hospital, Israel

Dr. Michael Reilly,
Executive Director, Alliance for Safe Biologic Medicine, USA

Dr. Luana Pesco Koplowitz,
Chief Medical & Scientific Officer, DUCK FLATS Pharma, USA

Dr. Tom Mander,
Chief Operating Officer, Domainex Ltd, UK

Dr. Lars Neumann,
Director, Proteros biostructures GmbH, Germany

Dr. Raphael Serreau,
Professor, Unité INSERM “Psycomadd“ Université Paris Sud, France

Dr. Sigrid Saaler-Reinhardt,
Director, Midas Pharma GmbH, Germany

Dr. Monica Berrondo,
CEO, Macromoltek - Molecular simulations simplified, USA

Dr. Andrea Cusack,
CBO, Leon-nanodrugs GmbH, Germany

Exhibition and Posters

SDDS-2021 provides an ideal platform to showcase your novel technologies and products in the Netherlands. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Why Reserve a Booth at SDDS-2021
• Meet with International Leaders and Senior Officers in the Field of Drug Delivery Systems
• Maximize Your Opportunities for Collaboration
• Explore Business Opportunities in Amsterdam and beyond
• Spotlight Your Technologies and Its Commercial Application
• Superior Networking Opportunities with Senior Professionals and Industry Elites


 

Exhibition Date:
Set-up date: July 14, 2021
Show dates: July 15-17, 2021
Place: Amsterdam, the Netherlands

Introduction to Amsterdam

Amsterdam is the capital city and most populous municipality of the Netherlands. Its status as the capital is mandated by the Constitution of the Netherlands. Amsterdam's main attractions include its historic canals, the Rijksmuseum, the Van Gogh Museum, the Stedelijk Museum, Hermitage Amsterdam, the Anne Frank House, the Scheepvaartmuseum, the Amsterdam Museum, the Heineken Experience, the Royal Palace of Amsterdam, Natura Artis Magistra, Hortus Botanicus Amsterdam, NEMO, the red-light district and many cannabis coffee shops. They draw more than 5 million international visitors annually. The city is also well known for its nightlife and festival activity; several of its nightclubs (Melkweg, Paradiso) are among the world's most famous. It is also one of the world's most multicultural cities, with at least 177 nationalities represented.

Cocurrent Conference
Hosting Organization

Foreign Experts Databank of SAFEA-Dalian Branch

Journal Partner
Media Partner List





































© 2003-2021 All rights reserved by BIT Group Global Ltd.
Contact Us: Tel: 0086-411-84799606, Fax: 0086-411-84796897